체외진단용 시약 및 세포배양 배지 시장 규모, 점유율, 성장 분석 : 제품 유형별, 용도별, 지역별 - 업계 예측(2026-2033년)

Global In Vitro Diagnostics And Cell Culture Medias Market size was valued at USD 82.8 Billion in 2024 and is poised to grow from USD 86.28 Billion in 2025 to USD 119.91 Billion by 2033, growing at a CAGR of 4.2% during the forecast period (2026-2033).

The in vitro diagnostics and cell culture media market is primarily driven by the rising need for precise and rapid biological data, essential for guiding clinical decisions and enhancing biopharmaceutical development. This market includes a variety of products such as assays, instruments, and reagents that support disease biomarker detection and cell growth for research and manufacturing. Diagnostic accuracy reduces treatment uncertainties, while high-quality media facilitates dependable biologics production, evident from increased testing demands and monoclonal antibody manufacturing. The convergence of precision medicine, cell therapy, and biologics manufacturing broadens opportunities across diagnostics and media supply chains. Innovations in custom formulations and single-use media formats are emerging to meet the growing demands of monoclonal antibody and vaccine production, optimizing manufacturing processes and mitigating contamination risks.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global In Vitro Diagnostics And Cell Culture Medias market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global In Vitro Diagnostics And Cell Culture Medias Market Segments Analysis

Global in vitro diagnostics and cell culture medias market is segmented by product type, application and region. Based on product type, the market is segmented into In Vitro Diagnostics (IVD) and Cell Culture Media. Based on application, the market is segmented into In Vitro Diagnostics (IVD), Cell Culture Media and End User. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global In Vitro Diagnostics And Cell Culture Medias Market

The global market for in vitro diagnostics and cell culture media is driven by the increasing expansion of research pipelines and development activities undertaken by biopharmaceutical companies. These firms require reliable assays and high-quality media for various processes such as discovery, screening, and biologics production, leading to a heightened demand for advanced solutions. As a result, suppliers are motivated to innovate formulations and scale up manufacturing, thereby improving product availability and diversity. This synergy between research and development needs fosters collaborative efforts throughout the value chain, further propelling market growth through ongoing procurement and technological advancements.

Restraints in the Global In Vitro Diagnostics And Cell Culture Medias Market

The global market for in vitro diagnostics and cell culture media faces notable challenges due to complex and evolving regulatory frameworks. These regulations impose significant compliance burdens that can hinder product introductions and inflate development costs. Manufacturers are required to navigate a variety of regional standards and demonstrate safety, performance, and quality, which can decelerate innovation and deter smaller companies from market participation. Additionally, these regulatory demands complicate international commercialization by necessitating extensive documentation and validation, ultimately slowing the pace at which new technologies become available in laboratories and hampering overall market growth, despite ongoing scientific advancements.

Market Trends of the Global In Vitro Diagnostics And Cell Culture Medias Market

The global in vitro diagnostics and cell culture media market is witnessing a significant trend towards the integration of AI-enabled technologies, which enhance diagnostic acceleration and streamline laboratory workflows. These innovative tools leverage machine learning algorithms for assay design and image interpretation, facilitating rapid iteration and increased reproducibility in diagnostic development. The synthesis of complex biological signals with clinical context is driving the emergence of predictive biomarkers and adaptive testing strategies, thereby amplifying clinical relevance. Additionally, automation in analytical pipelines is enhancing data curation and validation processes, fostering collaboration among diagnostics manufacturers, laboratories, and healthcare providers while enabling a wider range of assays suitable for decentralized care.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Case Studies

Global In Vitro Diagnostics and Cell Culture Medias Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• In Vitro Diagnostics (IVD)
  • Infectious Diseases
  • Oncology
  • Cardiovascular Diseases
  • Metabolic Disorders
  • Immunological Disorders
  • Others
• Cell Culture Media
  • Biopharmaceutical Production
  • Drug Discovery & Development
  • Diagnostics
  • Regenerative Medicine
  • Others

Global In Vitro Diagnostics and Cell Culture Medias Market Size by Application & CAGR (2026-2033)

• Market Overview
• In Vitro Diagnostics (IVD)
  • Infectious Diseases
  • Oncology
  • Cardiovascular Diseases
  • Metabolic Disorders
  • Immunological Disorders
  • Others
• Cell Culture Media
  • Biopharmaceutical Production
  • Drug Discovery & Development
  • Diagnostics
  • Regenerative Medicine
  • Others
• End User
  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutes
  • Others

Global In Vitro Diagnostics and Cell Culture Medias Market Size & CAGR (2026-2033)

• North America (Product Type, Application)
  • US
  • Canada
• Europe (Product Type, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genomatix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sigma-Aldrich
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10X Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations